US 8039593
Antibodies and immunotoxins that target human glycoprotein NMB
granted A61KA61K2039/505A61K47/6817
Quick answer
US patent 8039593 (Antibodies and immunotoxins that target human glycoprotein NMB) held by The United States of America, as represented by the Secretary, Health and Human Services expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Health and Human Services
- Grant date
- Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/505, A61K47/6817, A61P, A61P29/00